Olsson Cecilia, Sandin-Bojö Ann-Kristin, Bjuresäter Kaisa, Larsson Maria
Department of Health Sciences, Faculty of Health, Science and Technology, Karlstad University, Karlstad, Sweden.
Sex Disabil. 2016;34(4):367-388. doi: 10.1007/s11195-016-9459-3. Epub 2016 Oct 15.
Longitudinal studies exploring sexuality, body image and health-related quality of life (HRQoL) are lacking in patients treated with chemo- or chemoimmuno-therapy for hematologic malignancies. The aim was to describe and explore changes in sexuality, body image and HRQoL in patients treated for hematologic malignancies, from baseline until 6 months after treatment. Twenty patients above 45 years (median age 62) treated for DLBCL, CLL or AML participated. Data were collected at baseline, 1- and 6-months after treatment by means of three instruments: SAQ-S, BIS and EORTC QLQ-C30. The results showed that patients' sexuality was negatively affected 1 month after treatment, but after 6 months the patient reported scores had returned almost entirely to baseline scores. Body image was slight negatively affected after 1 month and after 6 months, 50 % reported that body image was not affected at all. Regarding HRQoL, patients reported gradually improved scores during the study period. Regression analysis showed that changes in sexuality and body image seemed to influence changes in HRQoL. This study has shown changes in sexuality, body image and HRQoL over time in patients above age 45 treated for hematologic malignancies. One month after treatment all three areas becomes negatively affected, and thereafter the patients' scores recovered to a great extent regarding these issues within 6 months. Sexuality and body image seem to be important aspects of HRQoL for these patients and need to be integrated in the cancer rehabilitation during and after treatment.
对于接受化疗或化疗免疫疗法治疗血液系统恶性肿瘤的患者,缺乏探索其性取向、身体形象和健康相关生活质量(HRQoL)的纵向研究。本研究旨在描述和探索血液系统恶性肿瘤患者从基线到治疗后6个月期间性取向、身体形象和HRQoL的变化。20名年龄在45岁以上(中位年龄62岁)、接受弥漫性大B细胞淋巴瘤(DLBCL)、慢性淋巴细胞白血病(CLL)或急性髓细胞白血病(AML)治疗的患者参与了研究。在基线、治疗后1个月和6个月通过三种工具收集数据:性功能问卷简表(SAQ-S)、身体意象量表(BIS)和欧洲癌症研究与治疗组织核心生活质量问卷(EORTC QLQ-C30)。结果显示,患者的性取向在治疗后1个月受到负面影响,但6个月后患者报告的分数几乎完全恢复到基线分数。身体形象在1个月后受到轻微负面影响,6个月后,50%的患者报告身体形象完全没有受到影响。关于HRQoL,患者报告在研究期间分数逐渐改善。回归分析表明,性取向和身体形象的变化似乎会影响HRQoL的变化。本研究显示了45岁以上接受血液系统恶性肿瘤治疗的患者性取向、身体形象和HRQoL随时间的变化。治疗后1个月,所有这三个方面都受到负面影响,此后患者在这些问题上的分数在6个月内有很大程度的恢复。性取向和身体形象似乎是这些患者HRQoL的重要方面,在治疗期间和治疗后的癌症康复中需要将其纳入考虑。